# Effect of Beginning a Renal Replacement Therapy on Obstructive Sleep Apnea in End Stage Renal Disease Patients

> **NCT02073344** · NA · SUSPENDED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 30 (estimated)

## Conditions studied

- Obstructive Sleep Apnea
- End Stage Renal Disease

## Interventions

- **PROCEDURE:** Renal replacement therapy
- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT02073344
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2014-03
- **Primary completion:** 2021-11
- **Final completion:** 2022-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02073344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02073344, "Effect of Beginning a Renal Replacement Therapy on Obstructive Sleep Apnea in End Stage Renal Disease Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02073344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
